ID   U-343MGa Cl2
AC   CVCL_S474
SY   U-343 MGa Cl2; U-343 MGa Cl 2
DR   Wikidata; Q54973571
RX   PubMed=2998609;
RX   PubMed=3497714;
RX   PubMed=6296418;
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4773 ! U-343MGa
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
RX   PubMed=2998609;
RA   Nister M., Heldin C.-H., Westermark B.;
RT   "Clonal variation in the production of a platelet-derived growth
RT   factor-like protein and expression of corresponding receptors in a
RT   human malignant glioma.";
RL   Cancer Res. 46:332-340(1986).
//
RX   PubMed=3497714;
RA   Nister M., Wedell B., Betsholtz C., Bywater-Ekegard M., Pettersson M.,
RA   Westermark B., Mark J.;
RT   "Evidence for progressional changes in the human malignant glioma line
RT   U-343 MGa: analysis of karyotype and expression of genes encoding the
RT   subunit chains of platelet-derived growth factor.";
RL   Cancer Res. 47:4953-4960(1987).
//
RX   PubMed=6296418; DOI=10.1002/jnr.490080236;
RA   Westermark B., Magnusson A., Heldin C.-H.;
RT   "Effect of epidermal growth factor on membrane motility and cell
RT   locomotion in cultures of human clonal glioma cells.";
RL   J. Neurosci. Res. 8:491-507(1982).
//